Bluejay Diagnostics (BJDX) Change in Cash (2020 - 2026)

Bluejay Diagnostics has reported Change in Cash for 7 years, with the latest figure at -$1.5 million in Q1 2026.

• Quarterly Change in Cash fell 24.84% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $568354.0 (up 24.93% YoY) and the FY2025 annual result came in at $862930.0, down 58.78% from the prior year.
• Change in Cash eased to -$1.5 million in Q1 2026 per BJDX's latest filing, from $2.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $5.4 million in Q2 2024 and troughed at -$3.3 million in Q1 2023.
• A 5-year average of -$903724.8 and a median of -$1.5 million in 2026 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 420.98% in 2024, down 9711.14% in 2024.
• Over 5 years, Change in Cash stood at -$3.2 million in 2022, then advanced by 9.64% to -$2.9 million in 2023, then soared by 49.32% to -$1.5 million in 2024, then soared by 243.25% to $2.1 million in 2025, then tumbled by 171.08% to -$1.5 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$1.5 million, $2.1 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.